Atlas Trials

Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer

Clinical trial NCT07717099 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07717099
Sponsor
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Hormone-Sensitive Prostate Cance
Start date
2026-09-01
Primary completion
2029-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.